Janus Henderson Global Life Sciences Fund Class T-beleggingsfonds (JAGLX): koers en nieuws - Google Finance

Financiën

HomepageJAGLX • Open-end beleggingsfonds

Janus Henderson Global Life Sciences Fund Class T

$ 80,44

31 dec · USD · MUTF · Disclaimer

BlackRock Health Sciences Opportunities Portfolio Investor A Shares

$ 64,73

SHSAX0,42%

Franklin Biotechnology Discovery Fund Class A

$ 165,74

FBDIX0,41%

Fidelity Select Health Care Portfolio

$ 28,43

FSPHX0,18%

ProFunds Biotechnology UltraSector Fund Investor Class

$ 67,30

BIPIX0,27%

Fidelity Advisor Biotechnology Fund - Class A

$ 37,44

FBTAX0,11%

Vanguard Health Care Fund Admiral Shares

$ 86,25

VGHAX0,37%

Janus Henderson Contrarian Fund Class D

$ 26,82

JACNX0,81%

ProFunds UltraNASDAQ-100 Fund Investor Class

$ 125,40

UOPIX1,68%

Rydex NASDAQ-100® 2x Strategy Fund Class C

$ 449,63

RYCCX1,71%

Fidelity Advisor Blue Chip Growth Fund - Class A

$ 265,68

FBCCX0,70%

Beleggingsfonds

Vorige slotkoers

$ 80,68

Rendement lopende jaar

24,87%

Kostenratio

0,92%

Categorie

Healthcare Sector Equity

Morningstar Rating

Netto activa

1,32 mld. USD

Rendement

0,17%

Initiële kosten

-

Ingangsdatum

31 dec 1998

Marktnieuws

Canadian stocks set records in 'jaw-dropping' year

S&P/TSX composite down more than 70 points, US stock markets in negative territory

Yahoo! Finance Canada

Reality Check: 3 Stocks Retirees Can Count On in Uncertain Times

The Globe and Mail

The TSX just had its biggest annual gain in over 15 years. Don’t expect a repeat

The Motley Fool Canada

3 TSX Stocks That Could Triple in 5 Years

S&P/TSX composite finishes lower to end the year, U.S. markets also slide

Zoeken

Zoekopdracht wissen

Zoekfunctie sluiten

Google-apps

Hoofdmenu